Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptamer Group Regulatory News (APTA)

Share Price Information for Aptamer Group (APTA)

Share Price is delayed by 15 minutes
Get Live Data
0.525    -0.025 (-4.55%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £18.14m
APTA Live PriceLast checked at - London Stock Exchange

Intraday Aptamer Group Share Chart

Date   Source Headline
15th May 20257:01 amRNSAptamer Announces New Data at ASGCT
15th May 20257:00 amRNSOptimer licensing agreements and repeat contracts
6th May 20257:00 amRNSAlzheimer’s test advanced and royalty agreement
30th Apr 20257:00 amRNSLicensing agreed for Optimer as vaccine adjuvant
29th Apr 20257:00 amRNS-RAptamer Presenting at ASGCT Annual Meeting
24th Apr 20257:00 amRNS-RNew Corporate Presentation and Investor Factsheet
11th Mar 20257:00 amRNSInterim Results
27th Feb 202512:50 pmRNSTR-1: Standard form notification of major holdings
25th Feb 20257:01 amRNSBlock Listing Interim Review
25th Feb 20257:00 amRNSNotice of Results and Investor Presentation
28th Jan 20252:56 pmRNSIssue of Equity in lieu of Director fees
28th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 202511:40 amRNSNotification of dealings by a director/PDMR
30th Dec 20247:00 amRNSHolding(s) in Company
19th Dec 20244:44 pmRNSNotification of dealings by a director/PDMR
19th Dec 20247:00 amRNSNew Development Contract
18th Dec 202410:53 amRNSTR-1: Standard form notification of major holdings
16th Dec 202411:28 amRNSNotification of dealings by a director/PDMR
12th Dec 20247:00 amRNSHolding(s) in Company
9th Dec 20243:30 pmRNSNotification of dealings by a director/PDMR
9th Dec 20241:47 pmRNSNotification of dealings by a director/PDMR
9th Dec 20247:00 amRNSGrant of Options and Director Fee Shares
6th Dec 20247:00 amRNSNew Scientific Advisory Board Members
5th Dec 20247:00 amRNSTechnical Update
4th Dec 20247:00 amRNS-RInvestor Webinar
29th Nov 202411:05 amRNSResults of 2024 Annual General Meeting
29th Nov 20247:00 amRNSAGM Statement
7th Nov 20247:00 amRNSAgreement extended with genetic medicines customer
6th Nov 20247:00 amRNSCommercial Trading Update
5th Nov 20247:00 amRNSPosting of Annual Report and Notice of AGM
22nd Oct 20247:00 amRNSFull Year Results for the 12mths to 30 June 2024
17th Oct 20247:00 amRNSNotice of Results and Investor Presentation
16th Sep 20247:00 amRNSDirector Appointment
3rd Sep 20247:00 amRNSAptamer extends contract with Unilever
27th Aug 20247:00 amRNSBlock listing Interim Review
20th Aug 20242:26 pmRNSHolding(s) in Company
16th Aug 20241:04 pmRNSTR-1: Standard form notification of major holdings
14th Aug 202411:34 amRNSTR-1: Standard form notification of major holdings
13th Aug 202412:57 pmRNSResult of General Meeting and Board Changes
1st Aug 20244:33 pmRNSSupplementary Conditional Placing for £60,000
24th Jul 20246:11 pmRNSPosting of Circular and Notice of General Meeting
24th Jul 202412:37 pmRNSFundraise to Raise £2.83 million
8th Jul 20247:05 amRNSUpdate on progress in Unilever partnership
8th Jul 20247:00 amRNSTrading Update
3rd Jul 20247:00 amRNSAgreement to explore Optimer vehicles for siRNA
24th Jun 20247:00 amRNSNew Contracts Announcement for Optimer Development
14th Jun 20247:00 amRNSPartnership with Microsaic Systems
31st May 20244:06 pmRNSHolding(s) in Company
28th May 20249:05 amRNSHolding(s) in Company
23rd May 20247:00 amRNSNew contracts with top ten pharma partners

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.